Abou-Ismail, M. Y., Arafah, Y., Fu, P., Cao, S., Schmaier, A. H., & Nayak, L. (2020). Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab. Front Med (Lausanne).
Styl cytowania ChicagoAbou-Ismail, Mouhamed Yazan, Yasmin Arafah, Pingfu Fu, Shufen Cao, Alvin H. Schmaier, i Lalitha Nayak. "Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide Vs. Rituximab." Front Med (Lausanne) 2020.
Styl cytowania MLAAbou-Ismail, Mouhamed Yazan, et al. "Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide Vs. Rituximab." Front Med (Lausanne) 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..